The independent source for health policy research, polling, and news.
7,401-7,420 of 112,980 results
As requested by the Biden administration, the Supreme Court justices will review a provision of the $6 billion Purdue Pharma settlement with state and local governments that would shield the Sackler family from civil lawsuits over its alleged role in the opioid crisis.
The Centers for Medicare and Medicaid Services publicly released warning letters sent to all states over the high number of people losing Medicaid coverage for reasons other than eligibility. At least 36 states are believed to be falling short in one of the key areas of concern: paperwork problems, long call center wait times, or slow application processing.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Editorial writers discuss variant EG.5, Mark Cuban's Cost Plus Drugs, internet delusions, and more.
NJ.com says the state Health Department is investigating cases among nine residents in Passaic and Bergen counties, where another cluster was detected last winter. Also: Washington State reported a second case of tick-borne anaplasmosis, and a woman in Dallas died from West Nile virus.
Proton pump inhibitors, when used for more than four years, could lead to a much higher risk for developing dementia, a report in USA Today says. Separate research links a loss of the sense of smell with warnings of future Alzheimer's disease. Also: a new blood test to predict Alzheimer's risk.
The San Francisco Chronicle notes the rate for teens aged 15 to 19 declined 40% in two years from 2020, possibly a sign the fentanyl epidemic "eased its grip" on this cohort. But New Hampshire Public Radio reminds us the opioid crisis is worsening in parts of the country.
Novo Nordisk's restrictions of U.S. starter dose supplies will stay in place for the coming financial quarters, with soaring demand to blame. Separately, a study suggests that half of all prescriptions for GLP-1 drugs like Wegovy could come from telehealth providers.
The Washington Post covers startling results from a new study that found short bursts of energetic, simple activities, like rushing to catch a bus, could lower risks of developing at least 13 types of cancer. But, according to other research, if you're a woman who wants to lower your liver cancer risk, avoid sugary drinks.
Researchers say that abnormal mitochondrial function was found in the heart, kidneys, and liver of patients with covid, which could help explain long covid. AP examines why doctors are still wrestling the problems of why long covid affects people's heart health so much.
Politico says the victory for abortion rights supporters in the recent Ohio vote is pushing some Republicans to press for a move away from the strictest anti-abortion policies. And The Washington Post says Democrats are now "eyeing new opportunities" to enshrine abortion rights.
An analysis of published hospital pricing and insurer payment data finds that commercial insurance payers were charged more than 2 times that of Medicare Advantage. The gap was even larger for surgical procedures.
In an inversion of what one may think of as rational, rising assaults and shootings of U.S. health care workers now mean hospitals and clinics are among the most dangerous places to work, Axios reports. Also in the news: an expansion of Amazon's One Medical; AI helping 911 operators; and more.
The online dashboard, run in partnership with the NHTSA, aims to ensure that medical aid is reaching people who need it the most during heat emergencies. Other climate news is on the wildfire in Hawaii, how heat affects birth control, and more.
Some veterans and survivors encountered error messages when filing PACT Act claims on the Veterans Affairs website. Wednesday was the deadline for applying for retroactive benefits for illness due to toxic-substance exposure during military service.
Today's early morning highlights from the major news organizations.
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
Read recent commentaries about pharmaceutical issues.
Editorial writers discuss the latest on reproductive rights.
© 2026 KFF